Abstract

TREX1, the major 3' DNA exonuclease in mammalian cells digests single-stranded DNA and double-stranded DNA with mismatched 3'. The deletion of TREX1 is associated with developing inflammatory myocarditis, cardiomyopathy and circulatory failure. In the present study, we determined the in vivo contribution of TREX1 in vascular function normotensive and hypertension mice. Wild type, Knockout heterozygous (TREX-/+) and homozygous (TREX-/-) mice were infused with and without Angiotensin II (Ang II, 400 ng/Kg/min) for 2 weeks. Interestingly, hypertension was blunted in TREX-/- infused with Ang II compared to wild type and TREX-/+ mice infused with Ang II. In Trex1−/− mice, mesenteric resistant artery (MRA) contraction in response to phenylephrine (PE) was significantly augmented and but no effect was observed on endothelium-dependent relaxation (EDR) in response to acetylcholine. The infusion of Ang II causes MRA endothelial dysfunction in wild type and TREX-/+ mice associated with reduced eNOS and Akt phosphorylation and increased NADPH activity. Importantly, MRA function was not impaired in TREX-/- infused with Ang II. In conclusion, this is the first time to determine that the deletion of TREX1 potentiates vascular smooth muscle cell contractile phenotype but in the mean time blunts the development of hypertension when mice infused with Ang II independently of vascular reactivity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.